6666 | 羅麗芬-KY - Stock Value & PE Ratio Analysis

3

24

15

Excellent Growth

AI analysis rates 6666 with the highest value score of 5.
It is mainly due to adequate operating cash flow, along with adequate saety shown in the balance sheet.
Over the past 3 months, 6666 has maintained a consecutive value rating of 5.0, slightly higher than the rating of 4.0 over the past 3 years, indicating continued upward trend in enterprise value.
Compared to all stocks in the Biotech. & Medical sector, 6666 has a higher value rating.

6666 Value Reference Factors

The Value score is derived from various data and factor information, integrated through AI algorithms. The following factors are part of the evaluation used by AI value scores.

Update to 2025/05/16 (Weekly Update)

6666 Financial Forecast

Unit : TWD

Update to 2025/5/17 (Quarterly Update)

6666 Earnings Table

Unit : TWD

QTR	Non-GAAP EPS	EPS YoY	EPS Surprise %	Sales	Sales YoY	Sales Surprise %	NPM
Current	0.58	93.3%	-	248.15M	4%	-	10.2%
2024Q4	-0.24	-2,500%	-	238.63M	-1.8%	-	-5.4%
2024Q3	0.67	81.1%	-	298.41M	29.1%	-	9.6%
2024Q2	0.97	-17.1%	-	350.87M	13.3%	-	12.7%
2024Q1	0.3	-6.3%	-	238.62M	27.4%	-	11.2%

Update to 2025/5/20 (Quarterly Update)

6666 Historical Value Score

You can use historical scores of 3 or above to observe potential performance and make investment decisions.

6666 Value Strategy Backtest

The following backtest is based on specified rules since 2007. Price chart shows buy/sell time, cumulative returns, and backtesting statistics.

Entry

Exit

The Backtest Result of 6666 from 2018/11 till Now

-43.13%
Cumulative Return: -8.65%
Annual Return: 26.22%
Volatility: -0.33
Sharpe Ratio

Statistics data for entering at or above a Value score of 4 and exiting at or below a Value score of 2 from November, 2018 to May, 2025. (Total Trades: 2)